Tumour model

HPAF-II

Pancreatic ductal adenocarcinoma
XenograftIn vitro

Model characteristics

Organism
Human
Tissue of origin
Pancreas
Pathology
Pancreatic ductal adenocarcinoma
Model type
In vitro, Xenograft
Availability
2 to 3 weeks

Request this model

Tell us about your compound and your endpoints. Our team confirms feasibility, timelines and study design before any commitment.

Related models

Other models sharing the same tissue of origin.

Model
Organism
Tissue of origin
Pathology
Type
Rat
Pancreas
Carcinoma
SyngeneicIn vitro
Rat
Pancreas
Carcinoma, azaserine induced
SyngeneicIn vitro
Human
Pancreas
Cystic fibrosis, Pancreatic ductal adenocarcinoma
XenograftIn vitro
Mouse
Pancreas
PDAC
SyngeneicIn vitroResistant
Human
Pancreas
Adenocarcinoma
XenograftIn vitro
Human
Pancreas
Pancreatic adenocarcinoma
XenograftIn vitro